Capricorn Fund Managers Ltd Invests $4.12 Million in Pfizer Inc. $PFE

robot
Abstract generation in progress

Capricorn Fund Managers Ltd recently invested $4.12 million to acquire a new stake of 165,569 shares in Pfizer Inc. during the fourth quarter. This move comes as Pfizer reported strong Q4 results, surpassing analyst expectations with $0.66 EPS and $17.56 billion in revenue, despite a slight year-over-year revenue decrease. Institutional investors collectively own a significant portion of Pfizer, holding about 68.36% of the company’s stock, while analysts currently maintain an average “Hold” rating with a target price of $28.19.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin